Ethyl biscoumacetate

Pharmaceutical drug
  • B01AA08 (WHO)
Identifiers
  • 3,3-(ethyl acetate-methylene)-bis(4-hydroxycoumarin)
CAS Number
  • 548-00-5 ☒N
PubChem CID
  • 11047
DrugBank
  • DB08794 checkY
ChemSpider
  • 10444159 checkY
UNII
  • 08KL644731
KEGG
  • D07131 checkY
ChEMBL
  • ChEMBL2106261 ☒N
CompTox Dashboard (EPA)
  • DTXSID3057771 Edit this at Wikidata
ECHA InfoCard100.008.128 Edit this at WikidataChemical and physical dataFormulaC22H16O8Molar mass408.362 g·mol−1
InChI
  • InChI=1S/C22H16O8/c1-2-28-20(25)15(16-18(23)11-7-3-5-9-13(11)29-21(16)26)17-19(24)12-8-4-6-10-14(12)30-22(17)27/h3-10,15,23-24H,2H2,1H3 checkY
  • Key:JCLHQFUTFHUXNN-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Ethyl biscoumacetate is a vitamin K antagonist.

References

  • The Merck Index, 12th Edition. 3818
  • v
  • t
  • e
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
Antiplatelet drugs
Glycoprotein IIb/IIIa inhibitors
ADP receptor/P2Y12 inhibitors
Prostaglandin analogue (PGI2)
COX inhibitors
Thromboxane inhibitors
Phosphodiesterase inhibitors
Other
Anticoagulants
Vitamin K antagonists
(inhibit II, VII, IX, X)
Factor Xa inhibitors
(with some II inhibition)
Heparin group/
glycosaminoglycans/
(bind antithrombin)
Direct Xa inhibitors ("xabans")
Direct thrombin (IIa) inhibitors
Other
Thrombolytic drugs/
fibrinolyticsNon-medicinal
Stub icon

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e